←Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Immunotherapy, Lung Cancer
Paul Paik
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Clinical Director, Thoracic Oncology Service
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Paul Paik is a thoracic medical oncologist with expertise in squamous NSCLC and MET exon 14 skipping tumors, contributing to tepotinib registration. He participates in perioperative IO trials integrating biomarker-driven cohorts. He is clinical director of thoracic oncology at MSK.
Share:
🧪Research Fields 研究领域
MET exon 14
tepotinib
squamous NSCLC
targeted therapy
perioperative drug development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Paul Paik 的研究动态
Follow Paul Paik's research updates
留下邮箱，当我们发布与 Paul Paik（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment